Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

322
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
322
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

141
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
141
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

6.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
6.2K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

94
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
94
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

132
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
132
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

87
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
87

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A statistical review of virus reduction in coagulation, flocculation, and sedimentation treatment processes.

Water research·2026
Same author

Breaking Down Silos: A Multidisciplinary Approach to Mitigate Indoor Airborne Pathogen Transmission.

Health security·2026
Same author

Making waves: Moving beyond the 1 in 10,000 benchmark in quantitative microbial risk assessment (QMRA) through evidence-informed risk approaches and systems decision-making.

Water research·2025
Same author

Can AI help authors prepare better risk science manuscripts?

Risk analysis : an official publication of the Society for Risk Analysis·2025
Same author

Foresight 2035: a perspective on the next decade of research on the management of Legionella spp. in engineered aquatic environments.

FEMS microbiology reviews·2025
Same author

Special issue: Risk science foundations in light of COVID-19.

Risk analysis : an official publication of the Society for Risk Analysis·2024
Same journal

Occurrence, Sources, and Export Rates of Ti-Bearing and Ce-Bearing (Nano)particles in the Seine River Where Engineered Nanoparticles Reach Natural Background Levels.

Environmental science & technology·2026
Same journal

Simulation-Guided Optimization of NH<sub>3</sub>/H<sub>2</sub> Cocombustion over a CuO Catalyst: Achieving High-Efficiency and near-Zero NO<sub><i>x</i></sub> Emissions.

Environmental science & technology·2026
Same journal

Heating-Induced Redistribution and Isotopic Fractionation of Soil Organic Carbon Among Density Fractions.

Environmental science & technology·2026
Same journal

High-Resolution Molecular Analyses Reveal Non-additive Impacts of Chronic Warming and Nitrogen Addition on Soil-Derived Dissolved Organic Matter.

Environmental science & technology·2026
Same journal

Distinct Source-Sink Patterns and Vertical Consumption of Alkyl and Aryl Organophosphate Esters in the Remote Ocean and Its Marginal Sea.

Environmental science & technology·2026
Same journal

Self-Regenerating PFOA Defluorination in Groundwater via Endogenous Electron Feedback in Biomimetic Molecular Trap.

Environmental science & technology·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K

Microbial dose response modeling: past, present, and future.

Charles N Haas1

  • 1Department of Civil, Architectural & Environmental Engineering Drexel University Philadelphia, Pennsylvania 19104, United States.

Environmental Science & Technology
|December 30, 2014
PubMed
Summary
This summary is machine-generated.

This study reviews pathogen risk assessment models, from basic dose-response to advanced epidemic dynamics. Future models should integrate in vivo data for better human health risk prediction.

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.6K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.4K

Related Experiment Videos

Last Updated: Apr 19, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.6K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.4K

Area of Science:

  • Pathogen risk assessment
  • Infectious disease modeling
  • Epidemiology

Background:

  • Human health risk from pathogens is assessed using a risk assessment framework.
  • Understanding the dose-response relationship is crucial for this framework.
  • Existing models have evolved through multiple generations, incorporating various factors.

Purpose of the Study:

  • To review the progression of pathogen dose-response models.
  • To identify opportunities for advancing infectious disease modeling.
  • To highlight the need for broader agent category inclusion and validation.

Main Methods:

  • Review of existing dose-response and epidemic modeling generations (1-3).
  • Discussion of limitations and future directions for advanced modeling.
  • Emphasis on incorporating in vivo physiological responses and host-pathogen dynamics.

Main Results:

  • Generation 1 models: probability of response to dose.
  • Generation 2 models: incorporate host/pathogen factors.
  • Generation 3 models: describe epidemic curve dynamics.

Conclusions:

  • Advancing beyond Generation 3 requires integrating in vivo data and individual host dynamics for population-level predictions.
  • Further research is needed for pathogens like amoebae and fungi.
  • Advanced models require validation with human outbreak data.